Cargando…

P2Y(2) receptor agonists for the treatment of dry eye disease: a review

Recent advances in the understanding of dry eye disease (DED) have revealed previously unexplored targets for drug therapy. One of these drugs is diquafosol, a uridine nucleotide analog that is an agonist of the P2Y(2) receptor. Several randomized controlled trials have demonstrated that the applica...

Descripción completa

Detalles Bibliográficos
Autores principales: Lau, Oliver C F, Samarawickrama, Chameen, Skalicky, Simon E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915022/
https://www.ncbi.nlm.nih.gov/pubmed/24511227
http://dx.doi.org/10.2147/OPTH.S39699

Ejemplares similares